Award notice Supplies
Test for amino acids in plasma and urine
- Public buyer
- HUS Group
Vantaa - Place of performance
- Vantaa
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 8 September 2026
- Notice language
- English
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
The HUS Group requests tenders to procure test kit(s) for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology. The test kit(s) should contain all needed assay dependent products like reagents, calibrators, the manufacturer’s control samples, the method parameters for the LC-MS/MS instrumentation, product support and all other products needed for the assay except ordinary laboratory necessity, e.g. laboratory water, pipettes or glassware. The products are described in more detail in below in the invitation to tender.
This is a total procurement, i.e. the procurement is not divided into lots. The offered solution must cover both plasma and urine testing. At present, the instrumentation available at HUS comprises LC from Shimadzu (Nexera 30 or 40) and MS/MS instruments from AB Sciex (5500+ Triple Quadrupole or Citrine) with Analyst MD 1.6.3.
Hotfix 4 or SCIEX OS software versions. In addition, basic laboratory instrumentation like mixers, incubators, pipetting robots and centrifuges are available. The kits are intended for the detection and quantitative analysis of amino acids in plasma and urine.
The amino acid profile allows diagnosis and monitoring of inborn errors of metabolism. At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. The runs are performed in approximately 2-3 batches a week and about 5-10 samples in one batch.
Samples should be able to prepare in vials. The contract period is 48 months. ESTIMATED VALUE At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly.
This is an estimate and the contracting entity does not commit to the stated consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33000000
Winning prices for comparable contracts
- A quarter below
- €480,000
- Median
- €1,100,000
- A quarter above
- €2,000,000
Amounts awarded (excl. VAT) over the last 3 years for 45 contracts in the same CPV group (3300…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Radioactive seeds for localizing breast cancer HUS Group · 24 September 2026 |
MoMedico ApS BXTAccelyon Ltd |
€1,100,000 |
| Intraoperative nerve stimulator for peripheral nerve surgery HUS Group · 3 July 2026 |
Ortus Medical ApS | €100,000 |
| TP23/26EU Angiografialaite Varsinais-Suomen hyvinvointialue · 23 October 2026 |
Philips Oy | €1,100,000 |
| PET-radiolääkeinjektori kulutustarvikkeineen Keski-Suomen hyvinvointialue · 23 October 2026 |
Cyclomedica Nordic AB | €270,490 |
| Urologiset tarvikkeet Sansia Oy · 20 October 2026 |
Adcare Oy Ab B. Braun Medical Oy Berner Oy Boston Scientific Nordic AB Coloplast Oy Endomed Oy Kebomed Oy Mediplast Fenno Oy Mediq Suomi Oy Olympus Finland Oy OneMed Oy ProMedical Oy Steripolar Oy UNOQUIP GmbH Walki Medical Oy Wellspect Oy |
€7,500,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 617797-2026.